ILiAD Biotechnologies Overview
- Founded
-
2012

- Status
-
Private
- Employees
-
12

- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$23.5M
- Investors
-
8
ILiAD Biotechnologies General Information
Description
Developer of a medical vaccine intended to prevent and offer treatment of human disease caused by Bordetella pertussis. The company's vaccine is a live attenuated pertussis vaccine inducing the immune system to produce protective antibodies against B. pertussis infection, enabling patients to recover from whooping cough and other serious diseases.
Contact Information
Website
www.iliadbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
- 4581 Weston Road
- Suite 260
- Weston, FL 33331
- United States
+1 (954) 000-0000
ILiAD Biotechnologies Timeline
ILiAD Biotechnologies Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Later Stage VC | 16-Mar-2021 | $23.5M | 000.00 | Completed | Clinical Trials - Phase 2 | |
7. Later Stage VC | 30-Mar-2020 | 00.00 | 000.00 | Completed | Clinical Trials - Phase 2 | |
6. Later Stage VC | 19-Dec-2018 | 000.00 | 000.00 | Completed | Clinical Trials - Phase 2 | |
5. Angel (individual) | 07-Feb-2018 | 00000 | 000.00 | Completed | Clinical Trials - Phase 1 | |
4. Seed Round | 13-Apr-2017 | 000 | 000.00 | Completed | Clinical Trials - Phase 1 | |
3. Angel (individual) | 13-Nov-2015 | 00000 | 00.000 | Completed | Clinical Trials - Phase 1 | |
2. Grant | $11.1M | $3.81M | Completed | Clinical Trials - Phase 1 | ||
1. Angel (individual) | $3.81M | $3.81M | Completed | Clinical Trials - Phase 1 |
ILiAD Biotechnologies Executive Team (7)
ILiAD Biotechnologies Board Members (9)
Name | Representing | Role | Since |
---|---|---|---|
Ariel Pablos-Mendez MD | ILiAD Biotechnologies | Board Member | 000 0000 |
Avi Naider | Self | Board Member | 000 0000 |
Bin Yan Ph.D | ILiAD Biotechnologies | Board Member | 000 0000 |
Corey Horowitz | Network-1 Technologies | Board Member | 000 0000 |
Cuong Do | Self | Board Member | 000 0000 |
ILiAD Biotechnologies Signals
ILiAD Biotechnologies Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Knott Partners Management | Hedge Fund | Minority | 000 0000 | 000000 0 | |
Thylacine Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Endo Investors | Venture Capital | Minority | 000 0000 | 000000 0 | |
JEMS venture capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Network-1 Technologies | Corporation | Minority | 000 0000 | 000000 0 |